Maggie Weinstein

Maggie Weinstein is a Medical Director at Zymeworks Inc. since July 2025, bringing a wealth of experience in the healthcare and biopharmaceutical sectors. Previously, Weinstein served as Associate Medical Director and Clinical Lead at Inhibrx Biosciences, Inc. from January 2022 to February 2025, where expertise included regulatory interactions and cross-functional team building. Prior roles include Clinical Scientist in Clinical Development at Adicet Bio, Inc., and a Senior Teaching Assistant in Clinical Research at Harvard T.H. Chan School of Public Health, where focus was on enhancing global clinical research capacity. Additionally, Weinstein worked as a Doctoral Researcher in Cancer Epidemiology at the University at Albany, SUNY, focusing on patient-centered planning and collaborative leadership in clinical research.